| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 13,971 | 12,616 | 11,469 | 15,387 | | Cost of Revenue | 8,478 | 7,835 | 7,614 | 10,544 | | | Gross Profit | 5,493 | 4,781 | 3,855 | 4,843 | | | Operating Expenses | | Research Development | 2,095 | 1,818 | 1,993 | 2,433 | | Selling General and Administrative | 4,971 | 5,186 | 5,395 | 7,358 | | Non Recurring |
-
|
-
|
-
| 27,701 | | Others | 144 | 145 | 146 | 582 | | | | Total Operating Expenses |
-
|
-
|
-
| 38,074 | | | | Operating Income or Loss | (1,717) | (2,368) | (3,679) | (33,231) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 294 | 543 | (457) | 440 | | Earnings Before Interest And Taxes | (1,423) | (1,825) | (4,136) | (32,791) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,423) | (1,825) | (4,136) | (32,791) | | Income Tax Expense | (4) | (249) | 29 | (1,379) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,419) | (1,576) | (4,165) | (31,412) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,419) | (1,576) | (4,165) | (31,412) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,419) | ($1,576) | ($4,165) | ($31,412) |
|
0.51% Nasdaq 
0.1501 (3.16%) 
Income Statement
